Published on
February 10, 2020
- 22:08 GMT
AngioGenex Co-Developping Anti-Cancer Drug with World Renowned Cancer Center
AngioGenex Co-Developping Anti-Cancer Drug with Memorial Sloan Kettering Cancer Center AngioGenex, Inc. (OTCBB:AGGX.PK) NEW YORK CITY, NY, US, February 10, 2020 /EINPresswire.com/ -- FOR IMMEDIATE RELEASE February 10, 2020 …
Distribution channels:
Banking, Finance & Investment Industry, Chemical Industry
...
